United States · Series E startup
3 rounds we have observed, with the 19 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$108Mraised across 3 rounds since 2005, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Alta Partners
Advent International
Roche Venture Fund
Forward Ventures
Astellas Venture Management
Pacific Venture CapitalReported by onbiovc.com
InterWest PartnersAlta Partners
GimvAdvent InternationalRoche Venture FundForward VenturesAstellas Venture Management
Pacific Venture Group
Handshake VenturesFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Nereus Pharmaceuticals's investors include Alta Partners, HBM BioVentures, Advent International, Forward Ventures and InterWest Partners, and 14 more on record.
Nereus Pharmaceuticals has raised $108M across 3 rounds since 2005.
Nereus Pharmaceuticals's most recent round was a Series E of $20M in Jun 2010.
Nereus Pharmaceuticals's largest round on record is $45M (Series D), in Aug 2007.
Nereus Pharmaceuticals's first round on record, in Oct 2005, was backed by InterWest Partners, Alta Partners and Gimv and 9 others.
Nereus Pharmaceuticals's latest named round is a Series E, in Jun 2010.
Nereus Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 